ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01407874
Recruitment Status : Completed
First Posted : August 2, 2011
Last Update Posted : November 20, 2013
Sponsor:
Information provided by (Responsible Party):
BioCryst Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012
  Certification/Extension First Submitted : October 4, 2013